Researchers have discovered that long-term glycemic control does not affect the risk of bacterial infection in type 2 ...

Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse ...

Lupin has been marketing the 'Huminsulin' range of products through existing distribution and promotion agreements with Eli ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to ...

A study published in BMC Nephrology suggests that COVID-19 is linked with a twofold increase in nephropathy and AKI in ...

Lupin has acquired 'Huminsulin' in India from Eli Lilly and Company to strengthen its diabetes portfolio. The acquisition ...

Lupin Ltd has acquired the anti-diabetic medicine Huminsulin in India from Eli Lilly to expand its diabetes portfolio. This ...

India is facing an alarming rise in metabolic syndrome, which is associated with Type-2 diabetes and other severe health ...

Lupin had been marketing Huminsulin through an existing agreement with Lilly India before proceeding to acquire the brand. Huminsulin is used in the treatment of Type 1 and Type 2 diabetes mellitus.

Lupin acquires Huminsulin from Eli Lilly to strengthen diabetes portfolio in India, offering affordable healthcare options.